Language Select
Varian Logo

Press Releases

October 03, 2018
Varian (NYSE: VAR), today announced it has appointed Kolleen T. Kennedy, formerly president of Varian Oncology Systems (VOS) to a new role as president of Proton Solutions, the division formerly... Read more
October 01, 2018
Varian (NYSE: VAR) today announced a 75-year-old male with throat cancer was the first patient in India to be treated on the Halcyon™ system at Sterling Cancer Hospital in Gujarat. Halcyon... Read more
September 20, 2018
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the... Read more
September 12, 2018
Varian (NYSE: VAR) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of... Read more
September 07, 2018
Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership agreement includes the supply of... Read more
September 04, 2018
Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on the campus of the Delray... Read more
August 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Baird Global Healthcare... Read more
August 22, 2018
Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2018 earnings release date and upcoming investor meeting at the American Society for Radiation Oncology (ASTRO) Annual Meeting.... Read more
August 21, 2018
Varian's (NYSE: VAR) president and chief executive officer, Dow R. Wilson, has joined the Board of Directors of the US-India Strategic Partnership Forum (USISPF). Mr. Wilson is among a group of... Read more
August 06, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held humediQ Global GmbH, the manufacturer of IDENTIFY, an automated patient identification, positioning and motion management... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com